Buy the Dip Monday: 78% Insider Buy Ratios, 8× Earnings, and Four 10/10 Names

This Week's Setup

This week's value screen surfaces banks, gas, solar, gold, and biotech on the same list because the math lines up: double-digit earnings yields, 10–29% drawdowns, and balance sheets that can fund the wait.

The top row is crowded at 10/10 scores: BANC at 0.94× book with an 8.3% FCF yield, CNX on gas at 5.6× EBITDA with net insider adds, FSLR down 29% with 40% gross margins intact, INCY at 15× earnings with 80% ROIC, NEM as the gold hedge at 9.3× EBITDA, PTCT at 8× earnings with 97% gross margins, ACAD down 24% with 49% implied upside, and EXEL with a 78% insider buy ratio and a 7.3% FCF yield.

If you are buying dips, start where cash yields already price stress and insiders are voting with personal capital.

The 8 Names

1. Banc of California, Inc. (BANC)

Stock Pixie Score 10.0/10 | P/B 0.94 | FCF yield 8.3% | Earnings yield 6.4%

The bank trades at 0.94× book with an 8.3% free cash flow yield, a setup that historically resolves when credit quality holds and deposit costs stabilize. The normalized P/E of 15.6 sits well below the sector median, and the 2.6% dividend yield adds tangible income while you wait for the 23% implied upside to the $22.55 analyst target.

The 15% drawdown reflects persistent concerns about commercial real estate exposure and net interest margin compression as deposits reprice higher. Debt-to-equity of 0.89 is manageable for a regional bank, but the stock has been dead money for the past year (trend 0.2%), so patience is required.

Insider activity over six months shows net selling of 12.6 million shares, but recent Form 4 filings from Nicholas Varischetti (March 27, March 30) and Karen Hon (April 1) indicate executives remain active; the insider-buy percentage of 1.4% is low, flagging weak internal conviction despite the surface metrics.

2. CNX Resources Corporation (CNX)

Stock Pixie Score 10.0/10 | P/E 9.9 | FCF yield 9.6% | EV/EBITDA 5.6

CNX posted 49% year-over-year revenue growth as natural gas realizations improved, and the 9.6% free cash flow yield at a 5.6× EBITDA multiple is rare in energy outside distressed names. ROIC of 11.1% and 47% gross margins confirm operational efficiency, and the company is using excess cash for buybacks (9.3% shareholder yield).

Insiders added a net 383,371 shares over six months, with the buy-to-sell ratio at 7.0-to-1.1; Maureen Lally-Green filed a purchase on March 25, reinforcing internal confidence. Short interest at 14.7% of float suggests a crowded short thesis that could unwind if gas prices stabilize or M&A speculation builds.

Analysts peg fair value at $37.15, 6% below the current $39.35 price, reflecting skepticism that gas pricing can hold at current levels through 2027. The 10% drawdown is modest, so the entry here is less about panic selling and more about positioning ahead of a potential commodity snapback.

3. First Solar, Inc. (FSLR)

Stock Pixie Score 10.0/10 | P/E 14.3 | Gross margin 40.6% | Revenue growth 24%

First Solar is down 29% from its peak despite 24% revenue growth and a 40.6% gross margin, a disconnect driven by tariff uncertainty and logistics-cost headlines rather than demand destruction. The 5.4% FCF yield and 14.3× earnings multiple are cheap for a U.S. solar OEM with a multi-year backlog and minimal debt (D/E 0.07).

Recent price-target cuts from Susquehanna ($250 from $280) cite rising logistics costs and module pricing pressure; the company's Q1 2026 earnings report (expected soon per Barchart) will clarify whether margin compression is transitory or structural. The 10-year normalized earnings yield of 2.7% remains thin, so you are paying for growth more than value optionality.

Insider net shares fell by 13,154 over six months, but recent filings from Michael Sweeney, Anita George, and Caroline Stockdale (March 17–April 1) show balanced activity with the buy-sell ratio nearly even (1.9% to 2.1%). Short interest at 7.7% is elevated enough to add volatility if results surprise positively.

4. Incyte Corporation (INCY)

Stock Pixie Score 10.0/10 | P/E 15.0 | ROIC 80.2% | Debt/Equity 0.01

Incyte trades at 15.0× earnings with an 80% return on invested capital and a 92.8% gross margin, fundamentals that reflect the high-margin economics of an established oncology and dermatology franchise. The 6.9% free cash flow yield and near-zero debt (D/E 0.01) give the company optionality to fund pipeline development or return cash without balance-sheet stress.

The 14% drawdown and flat one-year trend (0.2%) reflect investor fatigue with the core Jakafi franchise and uncertainty around new asset uptake; the normalized 10-year P/E of 35.9 suggests the market has historically paid a premium for growth that is no longer visible in consensus estimates. RBC's recent target adjustment to $95 from $92 signals low conviction on upside expansion.

Insiders sold a net 276,915 shares over six months, and recent Form 4 filings from Edmund Harrigan, Paul Clancy, and Matteo Trotta (March 26–April 2) show continued selling pressure; the 1.9% buy ratio versus 8.8% sell ratio flags weak internal optimism. The setup here is for patient capital that can wait through the pipeline maturation cycle.

5. Newmont Corporation (NEM)

Stock Pixie Score 10.0/10 | EV/EBITDA 9.3 | Gross margin 53.2% | ROIC 29.2%

Newmont trades at 9.3× EBITDA with a 53% gross margin and 29% ROIC, metrics that confirm the company can convert higher gold prices into meaningful free cash flow. The 5.8% FCF yield and 1.8% shareholder yield (dividend plus buybacks) add income, and the 13% drawdown creates an entry point as the YTD performance (+21% per Zacks) suggests momentum is turning.

Insiders added a net 8,092 shares over six months, with recent buys from David Fry (March 18) and Peter Toth (March 20, April 3); the 2.3% buy ratio versus 2.0% sell ratio is balanced, signaling executives are comfortable at current levels. Short interest at 1.7% is negligible, removing a volatility overlay.

The 18.4× P/E and $140 analyst target (19% upside) embed continued strength in gold prices; if macro conditions shift or geopolitical premiums fade, the stock could give back gains quickly. The 10-year earnings yield of 1.1% is low, so this is a commodity-price bet more than a value-income play.